California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva reaches $150 million deal with Texas to settle opioid-related claims | The Times of Israel
Teva CEO: Tough year ahead, but we're hitting cost-cutting targets - Israel News - The Jerusalem Post
Teva Pharmaceuticals - Wikiwand
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
U.S. accuses Israel's Teva of fixing drug prices
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Stocks making the biggest moves midday: Teva Pharmaceutical, Boeing, Uber & more
Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other
Teva CEO Says He's Still Hoping For a Nationwide Opioid Settlement | Barron's
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com
Teva Breaks Out Amid Hopes of Global Opioid Settlement
BDS movement on Twitter: "Another reason to boycott Israeli pharmaceutical giant TEVA. 40 U.S. states have accused TEVA and other drug companies of fraud. News report: https://t.co/qvQIuFr2ml https://t.co/NVPJhPWD4m" / Twitter
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
Teva to Close 11 More Manufacturing Facilities in 2019 | Ctech
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
FDA approves first generic version of epilepsy drug Sabril from Teva
Teva to Pay California $69 Million in Narcolepsy Drug Settlement | Ctech
Teva Pharmaceuticals - Wikipedia
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Patent Docs: Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2019)